Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 8,348 shares at $25.45 ($212K) on 2024-11-20, disclosed to the SEC on 2024-11-22.
Open-market sale of $212k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.45 | 4,174 | $106K | 50.0% |
| 2 | $25.45 | 4,174 | $106K | 50.0% |
| Total | $25.45 avg | 8,348 | $212K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |